PATENT CLAIM ANALYSIS

Application Number: 16007865
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "571000"]

Abstract:
The invention provides 1,3-diphenylprop-2-en-1-one derivatives and pharmaceutical compositions comprising the same for treating liver disorders, in particular those requiring the reduction of plasma level of biochemical markers such as aminotransferases. The 1,3-diphenylprop-2-en-1-one derivatives of General Formula (I) have hepatoprotective properties and can be used in methods for treating liver disorders involving the pathological disruption, inflammation, degeneration, and/or proliferation of liver cells, such as liver fibrosis or fatty liver disease.

Claim (Index 6):
The method according to  claim 1 , wherein X1 is an alkylthio group that comprises an alkyl group that is linear or branched, having from one to seven carbon atoms that is substituted or not by one or more halogen atoms.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 94.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14523191', '14933335', '15413963', '14288482', '13511170']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8505883706503976
- 35 USC 102 Novelty (BERT): 0.7066367676227469
- Combined Prediction Score: 0.8361932103476326
- Mean Citation Score: 638.4258000000002
- Max Citation Score: 749.5992
- Similarity Product: 740.1927157075881

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test